iShares China Large-Cap ETF (FXI)

Key Updates

FXI advanced 2.56% to $36.32 since the June 1 report, marking consecutive positive sessions for the first time since mid-May and recovering from the regulatory-induced selloff. The rebound reflects renewed investor confidence following improved U.S.-China diplomatic relations and growing optimism around China's AI ecosystem, though YTD losses remain substantial at -5.14%. Despite the recovery, the ETF continues trading well below its October 2025 highs, with regulatory uncertainty around cross-border trading and weak April economic data tempering bullish sentiment.

Current Trend

FXI has demonstrated short-term momentum with gains of 2.77% (1-day) and 1.59% (5-day), reversing the negative trend observed in recent months. However, medium-term performance remains challenged with losses of -1.33% (1-month), -8.03% (6-month), and -5.14% YTD. The ETF is trading at $36.32, significantly below the levels seen during the October 2025 rally when major China ETFs peaked before experiencing double-digit declines. The recent recovery suggests initial stabilization, but the ETF has yet to establish a sustained uptrend, remaining vulnerable to both regulatory developments and macroeconomic data releases. The price action indicates investors are cautiously re-entering Chinese equities following the diplomatic thaw between Washington and Beijing.

Investment Thesis

The investment case for FXI centers on China's economic stabilization, attractive valuations at 11 times 2027 forecast earnings (approximately half U.S. multiples), and expected earnings growth of 15% matching American levels. The thesis has strengthened with improved U.S.-China relations following the Trump-Xi summit, which reduced geopolitical risk premiums and opened discussions on tariff reductions on approximately $30 billion in goods. China's technology sector presents compelling opportunities driven by AI ecosystem expansion, with companies like Baidu reporting 49% revenue growth in AI-focused businesses and Zhipu achieving 132% revenue growth in 2025. Additionally, China's $1.2 trillion trade surplus in 2025, strengthening yuan (reaching its strongest level since 2023 at 6.784 against the dollar), and government support for technological innovation through the 15th Five-Year Plan provide structural tailwinds. However, the thesis faces material headwinds from Beijing's capital control crackdown targeting cross-border brokerages, weak April economic data, and foreign direct investment declining to $80 billion in 2025 from a $344 billion peak in 2021.

Thesis Status

The investment thesis remains intact but with heightened execution risk. The positive developments include easing geopolitical tensions, institutional support from UBS and Morgan Stanley (which raised targets projecting 8-12% upside through 2Q 2027), and record inflows of $1.22 billion into China and Hong Kong ETFs following the Trump-Xi meeting. China's technological advancement in semiconductor localization, AI, and biotech, combined with attractive valuations, supports the fundamental case. However, the May 26 regulatory crackdown on Futu Holdings, Tiger Brokers, and Longbridge Securities—which caused 25-28% declines in affected brokerages—introduces significant uncertainty around capital flow accessibility. This action directly contradicts the liberalization narrative and demonstrates Beijing's willingness to prioritize domestic market control over foreign investment appeal. The thesis now requires nimble positioning with emphasis on liquid, easily-exitable positions as recommended by Reuters, given the unpredictable regulatory environment. The technology sector focus remains valid, particularly for Hong Kong-listed H-shares which UBS favors over mainland A-shares due to superior valuations.

Key Drivers

Diplomatic Progress: The Trump-Xi summit reduced geopolitical risk premiums and initiated discussions on tariff reductions covering approximately $30 billion in goods, potentially lowering effective tariff rates by five percentage points, according to Bloomberg. This development allowed markets to refocus on fundamentals rather than escalation concerns.

AI Ecosystem Expansion: Chinese technology companies are demonstrating robust AI-driven growth, with Baidu reporting 49% revenue surge in AI-focused business to 13.6 billion yuan and Zhipu posting 132% revenue growth in 2025, as reported by CNBC. UBS has adopted a bullish stance on Chinese tech stocks based on this expanding ecosystem.

Regulatory Crackdown: China's securities regulator imposed severe penalties on three cross-border brokerages on May 26, confiscating illegal gains and mandating two-year account liquidation for mainland Chinese investors, causing 25-28% declines in affected companies, per Bloomberg. This reflects Beijing's determination to control capital outflows and redirect investment domestically.

Institutional Support: Morgan Stanley raised price targets projecting 8-12% upside through 2Q 2027 across major Chinese indexes, citing improved earnings, yuan appreciation, and China's strengthening position in global supply chains, according to CNBC. Global equity fund allocations to Chinese assets increased from 1.4% in early 2024 to 1.8% by February 2025, as noted by Reuters.

Capital Flows: China and Hong Kong ETFs received the largest inflow of $1.22 billion following the Trump-Xi meeting, with the KraneShares CSI China Internet ETF leading inflows, demonstrating renewed investor confidence as reported by Bloomberg.

Technical Analysis

FXI is currently at $36.32, showing short-term bullish momentum with consecutive daily gains totaling 2.56% since the last report. The ETF has established a near-term support level around $34.70 (May 28 low) and is testing resistance in the $36-$37 range. The 1-day gain of 2.77% and 5-day gain of 1.59% indicate strengthening buying pressure, though the 1-month decline of -1.33% suggests the recovery remains fragile. The ETF is trading approximately 11% below its October 2025 peak based on the reported declines from those highs. The yuan's strengthening to 6.784 against the dollar—its strongest level since 2023—provides a supportive backdrop for Chinese equities. Key resistance lies at the $37-$38 level, which if breached could signal a more sustained recovery. However, the ETF must overcome the -8.03% six-month decline to establish a convincing uptrend. Volume patterns following the $1.22 billion inflow into China ETFs suggest institutional participation is increasing, though the regulatory overhang may cap near-term upside.

Bull Case

• Attractive Valuation with Strong Growth Prospects: Chinese equities trade at 11 times 2027 forecast earnings—approximately half U.S. multiples—while expected earnings growth of 15% matches American levels, presenting compelling risk-reward according to Reuters. This valuation discount combined with comparable growth creates significant upside potential.
• AI-Driven Technology Sector Growth: Chinese tech companies are experiencing explosive AI revenue growth, with Baidu's AI business surging 49% to 13.6 billion yuan and Zhipu achieving 132% revenue growth in 2025, supported by government initiatives under the 15th Five-Year Plan, as reported by CNBC. This positions China as a major beneficiary of global AI adoption.
• Improved U.S.-China Relations and Tariff Relief: The Trump-Xi summit initiated discussions on tariff reductions covering approximately $30 billion in goods—roughly 10% of China's exports to the US—potentially lowering effective tariff rates by five percentage points, according to Bloomberg, reducing a major headwind for Chinese equities.
• Strong Institutional Support and Raised Price Targets: Morgan Stanley increased price targets projecting 8-12% upside through 2Q 2027 across major Chinese indexes, citing improved earnings, yuan appreciation, and strengthening global supply chain position, as detailed by CNBC, providing credible upside catalysts from a major investment bank.
• Record Capital Inflows and Increasing Allocations: China and Hong Kong ETFs received $1.22 billion in inflows following the Trump-Xi meeting, while global equity fund allocations to Chinese assets rose from 1.4% to 1.8%, demonstrating renewed institutional confidence as reported by Bloomberg and Reuters.

Bear Case

• Severe Regulatory Crackdown on Capital Flows: China's securities regulator imposed harsh penalties on three cross-border brokerages on May 26, confiscating all illegal gains and mandating two-year account liquidation, causing 25-28% declines in affected companies, demonstrating Beijing's willingness to restrict capital mobility despite foreign investment needs, per Bloomberg.
• Collapsed Foreign Direct Investment: Foreign direct investment plummeted to $80 billion in 2025 from a $344 billion peak in 2021, reflecting sustained foreign investor skepticism about China's business environment and regulatory unpredictability, as noted by Reuters, undermining long-term capital formation.
• Persistent Underperformance from October Highs: FXI remains down 11% from October highs, with peer ETFs MCHI down 13.6% and KWEB down 33%, indicating sustained selling pressure and failed rally attempts as reported by CNBC, suggesting structural headwinds persist.
• Chinese Acquisition Underperformance: Research analyzing 161,773 firms shows Chinese-acquired companies experienced a 1.1 percentage point decline in average return on assets compared to non-Chinese owned firms, with statistically insignificant patent increases despite increased R&D spending, questioning the value creation of Chinese investment strategies according to Financial Times.
• Limited Official Overseas Investment Quota: China's Qualified Domestic Institutional Investor program quota stands at only $176 billion—a fraction of the nation's 171 trillion yuan in household savings—demonstrating Beijing's structural commitment to capital controls that limit market accessibility, as highlighted by Bloomberg.